| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
14,380 | 10,027 | 8,253 | 7,109 | 4,825 | 3,096 | 2,290 | 2,286 | 2,413 |
General and administrative | ||||||||
3,478 | 2,922 | 2,316 | 2,466 | 1,250 | 746 | 584 | 357 | 347 |
Total operating expenses | ||||||||
17,858 | 12,949 | 10,569 | 9,575 | 6,075 | 3,842 | 2,874 | 2,643 | 2,760 |
Loss from operations | ||||||||
-17,858 | -12,949 | -10,569 | -9,575 | -6,075 | -3,842 | -2,874 | -2,643 | -2,760 |
Interest income | ||||||||
682 | - | 711 | 513 | 394 | - | 353 | 81 | - |
Interest expense | ||||||||
- | - | - | - | - | 0 | 0 | 358 | 599 |
Change in fair value of derivative liability | ||||||||
- | - | - | - | - | 0 | 0 | -188 | -18 |
Net loss | ||||||||
-17,176 | -12,379 | -9,858 | -9,062 | -5,681 | -3,470 | -2,521 | -3,108 | -3,377 |
Other comprehensive income/ (loss): | ||||||||
Unrealized gain / (loss) on available for sales securities | ||||||||
-97 | -36 | 16 | 103 | 26 | - | -16 | - | - |
Total comprehensive loss | ||||||||
-17,273 | -12,415 | -9,842 | -8,959 | -5,655 | -3,503 | -2,537 | -3,108 | -3,377 |
Net loss per share - basic and diluted | ||||||||
-0.61 | 0.61 | -0.37 | -0.57 | -1.61 | -1.02 | -0.75 | -0.93 | -1.01 |
Weighted average shares of common stock outstanding - basic and diluted | ||||||||
28,261 | 29,916 | 26,841 | 15,849 | 3,521 | 3,367 | 3,361 | 3,360 | 3,359 |